For this reason, serum AMH was included, for the first time, as an alternative to polycystic ovarian morphology (PCOM) by ultrasound in adults in the 2023 International Evidence-based Guidelines for the Assessment and Management of PCOS [5]. The gene discussed is AMH; the disease is polycystic ovary syndrome.